When differentiating tumor origin, pathologists frequently exploit immunohistochemical profiles to achieve a tissue diagnosis.14,15 The basic immunohistochemistry panel delineates cancer cell lineage, using antibodies against leukocyte common antigen (LCA) for lymphoma, S100 and MART-1 for melanoma, cytokeratins such as AE1/AE3 and CAM5.2 for carcinoma, and vimentin for sarcoma. This evidence concerns the gene SLC4A1 and neoplasm.